Cargando…
A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm
INTRODUCTION: In the USA, psoriasis affects approximately 3% of the population and costs more than $110 billion annually. The development of targeted biologics has revolutionized psoriasis management, but at an increasing cost. According to Joint AAD/NPF guidelines, an important need exists to ident...
Autores principales: | Strober, Bruce, Pariser, David, Deren-Lewis, Ann, Dickerson, Tobin J., Lebwohl, Mark, Menter, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484423/ https://www.ncbi.nlm.nih.gov/pubmed/34275121 http://dx.doi.org/10.1007/s13555-021-00573-1 |
Ejemplares similares
-
A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17
por: Armstrong, April W., et al.
Publicado: (2022) -
Alcohol and Psoriasis for the Dermatologist: Know, Screen, Intervene
por: Kearney, Niamh, et al.
Publicado: (2022) -
Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes
por: Lewis, Dana M., et al.
Publicado: (2022) -
Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists
por: Strober, Bruce, et al.
Publicado: (2021) -
Switching Inhalers: A Practical Approach to Keep on UR RADAR
por: Kaplan, Alan, et al.
Publicado: (2020)